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Memory deficits in Parkinson’s disease are
associated with reduced beta power
modulation
Hayley J. MacDonald,1,2 John-Stuart Brittain,2,3 Bernhard Spitzer,4 Simon Hanslmayr2,3
and Ned Jenkinson1,2
There is an increasing recognition of the signiﬁcant non-motor symptoms that burden people with Parkinson’s disease. As such,
there is a pressing need to better understand and investigate the mechanisms underpinning these non-motor deﬁcits. The electrical
activity within the brains of people with Parkinson’s disease is known to exhibit excessive power within the beta range (12–30
Hz), compared with healthy controls. The weight of evidence suggests that this abnormally high level of beta power is the cause of
bradykinesia and rigidity in Parkinson’s disease. However, less is known about how the abnormal beta rhythms seen in
Parkinson’s disease impact on non-motor symptoms. In healthy adults, beta power decreases are necessary for successful episodic
memory formation, with greater power decreases during the encoding phase predicting which words will subsequently be remem-
bered. Given the raised levels of beta activity in people with Parkinson’s disease, we hypothesized that the necessary decrease in
power during memory encoding would be diminished and that this would interfere with episodic memory formation. Accordingly,
we conducted a cross-sectional, laboratory-based experimental study to investigate whether there was a direct relationship between
decreased beta modulation and memory formation in Parkinson’s disease. Electroencephalography recordings were made during
an established memory-encoding paradigm to examine brain activity in a cohort of adults with Parkinson’s disease (N¼ 28, 20
males) and age-matched controls (N¼31, 18 males). The participants with Parkinson’s disease were aged 6566 years, with an
average disease duration of 66 4 years, and tested on their normal medications to avoid the confound of exacerbated motor symp-
toms. Parkinson’s disease participants showed impaired memory strength (P¼0.023) and reduced beta power decreases
(P¼ 0.014) relative to controls. Longer disease duration was correlated with a larger reduction in beta modulation during encod-
ing, and a concomitant reduction in memory performance. The inability to sufﬁciently decrease beta activity during semantic proc-
essing makes it a likely candidate to be the central neural mechanism underlying this type of memory deﬁcit in Parkinson’s disease.
These novel results extend the notion that pathological beta activity is causally implicated in the motor and (lesser appreciated)
non-motor deﬁcits inherent to Parkinson’s disease. These ﬁndings provide important empirical evidence that should be considered
in the development of intelligent next-generation therapies.
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IFC¼ inferior frontal cortex; LH¼ low confidence hit; M¼Miss; RM¼ repeated measures; SME¼ subsequent-memory effect
Introduction
Parkinson’s disease is classified as a movement disorder.
However, there is growing recognition that non-motor
burdens also significantly impact those suffering with the
condition. Non-demented Parkinson’s disease patients can
experience cognitive difficulties, including long-term mem-
ory deficits (for a review see Raskin et al., 1990;
Zgaljardic et al., 2003) and specifically the ability to
recall verbal memory (Cohn et al., 2010; Dujardin et al.,
2015; Edelstyn et al., 2015).
One striking feature of Parkinson’s disease demon-
strated repeatedly over the last 20 years is that the elec-
trical activity recorded from basal ganglia (BG) networks
in people with Parkinson’s disease exhibits excessively
high levels of activity within the beta frequency range
(12–30 Hz) compared with healthy controls. Under nor-
mal circumstances, beta activity is modulated with
Graphical Abstract
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voluntary movement, where the amplitude of oscillations
(power) in the beta range drops at the onset of move-
ment and rises again at the end. It is suggested that ele-
vated beta is associated with tonic motor state and an
event-related power decrease within BG networks ‘allows’
movement to take place (Joundi et al., 2013; Brittain and
Brown, 2014), and as such the excessively high beta ac-
tivity seen in Parkinson’s disease prevents decreases in
power and thus interferes with voluntary movement
(Jenkinson and Brown, 2011). Indeed, therapies that re-
duce beta activity, such as dopamine replacement therapy
(Ray et al., 2008) or deep brain stimulation (Eusebio
et al., 2011), also proportionately improve bradykinesia
and rigidity (Ray et al., 2008). Interestingly, decreases in
beta power can also occur in the absence of motor out-
put during imagined voluntary movements (McFarland
et al., 2000; Miller et al., 2010). However, to date the
link between exaggerated beta activity and motor symp-
toms in Parkinson’s disease remains circumstantial and
correlative. It therefore remains an unresolved question as
to whether pathological beta activity is causal or an
epiphenomenon.
Given that beta power is elevated throughout the BG–
thalamocortical circuitry in Parkinson’s disease and that
this elevation has been observed over broad areas of
frontal cortex (Litvak et al., 2011), we postulated that
the excessive beta power seen in Parkinson’s disease
should interfere with other neural mechanisms that nor-
mally operate within this spatial domain. Identifying such
beta dependent processes and demonstrating a deficit of
function in Parkinson’s disease would provide further evi-
dence that increased beta power is responsible for the
motor and non-motor symptoms of the disease. Recent
experimental evidence suggests a role for beta oscillations
in the encoding of explicit long-term memory.
Specifically, a greater reduction of beta power occurs in
the left inferior frontal cortex (IFC) during memory for-
mation of words that are subsequently remembered com-
pared with those that are not (Sederberg et al., 2003;
Hanslmayr et al., 2009, 2011; Meeuwissen et al., 2011;
Meconi et al., 2016). This relationship is especially strong
if the explicit memory strategy requires semantic process-
ing (Hanslmayr et al., 2009). Memory strategies utilizing
semantic processing are examples of deep encoding; when
people engage with the meaning of the words, e.g. put
them into the context of a sentence or make a judgement
about whether they relate to living/nonliving entities.
Conversely, in shallow encoding an individual only
engages with the presented items on a superficial and
more perceptual level, as opposed to a cognitive level
(Craik and Lockhart, 1972). Examples are detecting
whether a presented word contains a specific letter, or
whether the first and last letters of the word are in al-
phabetical order (Otten et al., 2001). Unlike in deep
encoding, decreases in beta power during shallow encod-
ing are not predictive of memory performance
(Hanslmayr et al., 2009). Furthermore, a decrease in beta
power is not seen when similar words are deeply encoded
but using non-semantic strategies (Fellner et al., 2013).
Therefore, it appears that decreases in beta power are
specifically driven by the semantic nature of the encoding
task. If the explicit motor deficits in Parkinson’s disease
are a result of increased beta power in motor areas of
the brain, it stands-to-reason that the memory deficits
may well be the result of the elevated levels of beta activ-
ity, which prevent the encoding driven decrease in beta
power required for semantic processing, and memory for-
mation as a result thereof.
Employing a semantic-encoding memory task to investi-
gate the role of pathological beta in Parkinson’s disease
has several advantages. First, it removes the confound of
movement during the window for beta power decreases.
Therefore, if a relationship exists between behaviour and
beta power, this would argue against impaired beta
decreases seen in the motor system being an epiphenom-
enon that merely reflects the paucity of movement in peo-
ple with Parkinson’s disease. Second, semantic processing
(Gabrieli et al., 1998) and episodic memory formation
(Otten and Rugg, 2001) recruit the ‘left’ IFC. This is im-
portant since dynamic modulation of beta has already
been shown to be compromised in Parkinson’s disease
within the cortical–BG network including ‘right’ IFC and
subthalamic nucleus (Swann et al., 2009, 2011; Brittain
et al., 2012). Given the coherent beta activity within cor-
tico-BG circuitry (Hirschmann et al., 2011; Litvak et al.,
2011) and bidirectional communication (Lalo et al.,
2008; Horschig et al., 2015) within these circuits, we
would predict that pathological beta would equally affect
‘left’ IFC beta power and therefore impair episodic
memory that recruits semantic-encoding strategies.
Intriguingly, it has been demonstrated behaviourally that
Parkinson’s disease patients do show a specific memory
deficit when recollecting deep-encoded words but no def-
icit in shallow-non-semantic encoding (Cohn et al.,
2010). If this specific deficit can be shown to be associ-
ated with the inability to sufficiently decrease beta activ-
ity, it would demonstrate that impaired modulation of
beta might underlie at least some of the higher cognitive
symptoms associated with the disease. Finally, we have
demonstrated a causal relationship between beta power
decreases in left inferior prefrontal cortex and memory
performance in young healthy adults (Hanslmayr et al.,
2014). Elucidating a direct relationship between beta
power and episodic memory performance in Parkinson’s
disease would therefore strongly argue for a causal role
of exaggerated beta oscillations in the symptoms of
Parkinson’s disease.
Given this background, the current study aimed to de-
termine whether there is a direct relationship between
impaired decreases in beta power and the long-term
memory deficits observed in non-demented Parkinson’s
disease. The study design, hypotheses and analyses were
preregistered (MacDonald et al., 2016). We recorded sur-
face electroencephalography (EEG) during an established
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memory-encoding paradigm to examine beta oscillations
in Parkinson’s disease patients and healthy controls dur-
ing deep-semantic and shallow-non-semantic encoding.
We hypothesized that Parkinson’s disease patients would
exhibit impaired memory performance compared with
healthy controls following deep-semantic encoding but
that there would be no difference in memory performance
between groups following shallow-non-semantic encoding.
We further hypothesized that Parkinson’s disease patients
would show reduced beta power decreases during deep-
semantic encoding compared with healthy controls but
that there would be no difference in beta power between
groups during shallow-non-semantic encoding.
Materials and methods
The study was approved by the University of Birmingham
Research Ethics Committee (ERN_09-528AP20), and writ-
ten informed consent was obtained from each participant.
Data collection was carried out during a single laboratory
session for each participant at the University of
Birmingham.
Behavioural task
Participants were seated 1m from a 19-in computer
monitor. Stimuli were presented in black text against a
grey background using the Psychophysics Toolbox exten-
sion of MATLAB (Brainard, 1997). The task was divided
into eight blocks, and each block was divided into three
stages (Fig. 1).
First, there was an ‘encoding stage’ that required either
deep-semantic encoding or shallow-non-semantic encoding
of 30 words presented on the screen one at a time. All
participants completed four blocks of trials of each
encoding condition (i.e. encoding blocks). The order of
presentation of each encoding type was counterbalanced
across participants. In the deep-semantic-encoding blocks,
participants judged whether the presented word was ani-
mate, i.e. whether it referred to the property of a living
entity. In the shallow-non-semantic-encoding blocks, par-
ticipants judged whether the first and last letters of the
word were in alphabetical order. These encoding instruc-
tions have been used previously to investigate subsequent-
memory effects (SME) (Otten and Rugg, 2001;
Hanslmayr et al., 2009). Participants responded on each
trial by pressing one of two response buttons (‘yes’ or
‘no’) on the keyboard using their index and middle fin-
ger. Parkinson’s disease patients used fingers on their less
affected hand, and hand assignment was randomized (re-
gardless of hand dominance) across healthy participants
for comparison with patients. Button assignment was
counterbalanced across patients and participants.
The encoding stimuli were taken from a pool of 240
English words, with a list of 120 per encoding condition
selected from the Medical Research Council (MRC)
psycholinguistic database (Coltheart, 1981). Encoding lists
were matched according to word frequency (10–93 per
million), concreteness (252–593), imageability (452–615),
number of syllables (1–4) and number of letters (3–10).
Words were randomly drawn from the first encoding list
for the first four encoding blocks, and the second list for
the last four blocks. The order of encoding instructions
rather than encoding lists was counterbalanced across
participants. A single trial began with a fixation cross for
a variable duration of between 1500 and 2000ms, fol-
lowed by word presentation for 2000ms and ended with
a question mark to prompt the participant to respond
(for which they were given 2500ms). Participants were
instructed not to react during word presentation but give
their response during presentation of the question mark.
The second stage in each block consisted of a distracter
task during which 20 faces of famous and non-famous
people were presented to the participant one at a time.
The participant was required to rate the attractiveness of
each face using a 6-point rating scale. The distracter
stage was intended to prevent the participants rehearsing
the word lists and also to familiarize participants with
the 6-button ratings, which were to be used in the subse-
quent recognition stage.
In the final ‘recognition stage’ of each block, the 30
previously encoded words and 15 novel stimuli words
drawn from the same pool of English database words
were presented to participants one at a time. The lists of
encoded and novel words were kept consistent between
participants. The order of words was randomized, and
participants were required to rate their confidence as to
whether the word was one encountered in the ‘encoding
stage’, or was a new word. Ratings were given using the
6-point rating scale where response options were R1: rec-
ollect, R2: very familiar, R3: familiar, R4: unsure new,
R5 sure new, R6: very sure new, using buttons pressed
with the index, middle and ring fingers on both hands.
The assignment of the buttons was counterbalanced
across participants (i.e. R1–R6 versus R6–R1), and par-
ticipants were explicitly instructed to use the full range of
Figure 1 Three stages of memory task. The letters in
brackets indicated to participants that button on the keyboard
corresponded to which response. In the final screen for a
recognition trial, participants saw assigned responses (i.e.
recollection, very familiar, etc.) rather than R1–R6, which are
shown here due to space constraints.
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confidence ratings. The list of new words was matched
to encoding lists for word frequency, concreteness, image-
ability, number of syllables and number of letters. A trial
progressed in the same order and with the same timings
as during the ‘encoding stage’, except that the question
mark and button prompts remained on-screen until the
participant responded.
Electroencephalography recording
Continuous EEG data were recorded using a 128-channel
BioSemi ActiveTwo system (BioSemi) with electrodes posi-
tioned at the 128 standard equidistant BioSemi sites.
Data were digitized using the BioSemi ActiView software,
with a sampling rate of 1024Hz and filtered between 0.1
and 100Hz.
Behavioural data analysis
Reaction times and response accuracies were recorded
during the ‘encoding stage’. Response times were calcu-
lated from the onset of the question mark, which
prompted the participant to respond until button press.
Accuracy was calculated as the number of correct ‘yes’ or
‘no’ responses during each type of encoding expressed as
a percentage of all words presented for that encoding
condition. All other behavioural analysis and presented
data are from the ‘recognition stage’. Trials in the recog-
nition stage were grouped into high confidence hit (HH),
low confidence hit (LH) and Miss (M) categories, de-
pending on the participant’s response and their individu-
alized receiver operating characteristic curves (Hanslmayr
et al., 2009). Using receiver operating characteristic
curves enabled objective quantification of individual re-
sponse biases and corrected for participants’ tendencies to
use single buttons of the rating scale differently (Fig. 2).
There was an average of 101 (minimum 66/maximum
118) of these remembered (HH and LH) trials for con-
trols and 98 trials (minimum 66/maximum 118) for
Parkinson’s disease participants in deep-semantic encoding
and 71 trials for both controls (minimum 33/maximum
98) and Parkinson’s disease participants (minimum 25/
maximum 103) in shallow-non-semantic encoding. For M
trials, there were an average of 19 (minimum 2/maximum
54) for controls and 22 (minimum 2/maximum 54) for
Parkinson’s disease participants in deep-semantic encoding
and an average of 49 trials for both controls (minimum
22/maximum 87) and Parkinson’s disease participants
(minimum 17/maximum 95) in shallow-non-semantic
encoding. The primary dependent variable, memory
strength (d0), was calculated from recognition responses
using the following equation:
d
0 ¼ Z % Hits½   Z % false alarms½ :
Z scores were calculated for each individual using
MATLAB (The Mathworks). Hits refer to combined HH
and LH responses when a word is correctly remembered.
False alarms are responses where the participant has in-
correctly identified a new word as remembered.
EEG data analysis
All EEG analysis and presented data are from the ‘encod-
ing stage’. Offline analysis was performed in MATLAB
using the open-source FieldTrip toolbox (Oostenveld et al.,
2011) and in-house MATLAB functions. Raw EEG data
were high-pass (1Hz) and low-pass filtered (40Hz) with fi-
nite impulse response filters, re-referenced to the average
reference, down-sampled to 500Hz and epoched into
7000ms segments around word presentation (3000ms pre-
stimulus onset to 4000ms post-stimulus onset) for prepro-
cessing. Independent component analysis allowed compo-
nents related to ocular artefacts to be visually identified
and removed before subsequent visual inspection and man-
ual removal of remaining artefacts. If any channels had
been removed during artefact rejection (mean 0.6 channels
removed, minimum: 0, maximum: 3), sensor data were
interpolated via triangulation of nearest neighbour and
then finally re-referenced to the average reference.
The EEG recording epochs extracted from individual
encoding trials were grouped into HH, LH and M cate-
gories, depending on the participant’s subsequent re-
sponse in the ‘recognition stage’. Epochs were further
segmented from 750ms pre-stimulus to 2000ms post-
stimulus after filtering for the time–frequency analysis
(shorter segmentation at this stage is to remove edge arte-
facts from filtering). The entire power spectrum was cor-
rected for 1/f (Podvalny et al., 2015; Voytek et al., 2015)
by fitting a linear function to the log-transformed data
for every time point and then subtracting the linear fit.
The 2.75-s epochs were then subjected to a Morlet wave-
let transformation (width of 7 cycles) as implemented in
Fieldtrip to extract time-frequency characteristics at fre-
quencies 2–40Hz in steps of 1Hz. Average power values
Figure 2 Receiver operating characteristic curves for a
representative control. (A) and Parkinson’s disease participant
(B) in deep-semantic- and shallow-non-semantic-encoding
conditions. The false alarm rate is cumulative. The responses given
on the 6-point rating scale are grouped into the following
conditions: HH, LH and M.
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were calculated for each trial type (HH, LH and M) and
baseline corrected (relative change, baseline 750 to
250ms). This baseline duration is common to examine
beta power modulation in memory paradigms (e.g.
Hanslmayr et al., 2009; Meconi et al., 2016) and the
timing avoids filter smearing from post-stimulus effects
into the baseline period. The primary dependent measure
was beta power decrease for words that were subsequent-
ly successfully remembered, regardless of confidence level
(i.e. during successful encoding of a memory resulting in
a HH or LH trial in the ‘recognition stage’). The second-
ary dependent measure was the SME in beta power
which compared power between Hit (i.e. subsequently
remembered with high or low confidence) and M (i.e.
subsequently forgotten) trials (Brewer et al., 1998; Otten
et al., 2001; Hanslmayr et al., 2009). All analyses of
beta power between and within groups used the same
number of trials (adding to a total of 120 Hits/M) as the
behavioural analysis except for trials that were removed
before being categorized as Hit/M due to EEG artefact
(controls: average of two trials removed, range 0–30 for
deep-semantic condition; average of four trials removed,
range 0–31 for shallow-non-semantic condition;
Parkinson’s disease: average of two trials removed, range
0–7 for deep-semantic condition; average of one trial
removed, range 0–5 for shallow-non-semantic condition).
A minimum of five trials for Hits and/or M was required
for a participant to be included in the beta power
analyses.
Statistical analysis
For memory strength (d0), participants who had values
outside 3 SD of the group mean were removed using the
median absolute deviation method. The Shapiro–Wilk test
ensured normality before using a mixed-effects repeated-
measures (RM) 2  2 analysis of variance (ANOVA)
with factors group (controls, Parkinson’s disease) and
encoding (deep, shallow) as per our preregistered proto-
col expecting a group  encoding interaction
(MacDonald et al., 2016). Post hoc and planned compar-
isons were performed using t-tests. A least absolute
shrinkage and selection operator regression was per-
formed for the Parkinson’s disease group to determine
the capacity of age and/or disease duration to predict
memory strength following deep-semantic and shallow-
non-semantic encoding, accounting for collinearity be-
tween age and disease duration. A mixed-effects RM 2 
2 ANOVA with factors group (controls, Parkinson’s dis-
ease) and encoding (deep, shallow) tested for differences
between groups in encoding accuracy and reaction time
for the two encoding conditions.
In alignment with previous EEG studies, and as per
our preregistered protocol, post-stimulus beta power
decreases are expected to be associated with successful
memory formation in healthy (Hanslmayr et al., 2009,
2011) and patient populations (Meconi et al., 2016).
Therefore, lower beta from 12 to 20Hz was the main
frequency range of interest for all dependent measures
(see https://osf.io/vb64n/). We did, however, conduct add-
itional between group analyses within the alpha (8–
11Hz) and theta range (4–7Hz) using the same steps as
for beta power to rule out widespread frequency changes
and confirm that our results were specific to beta.
Only negative clusters in the beta frequency range were
expected so comparisons of scalp-wide group averaged
data were subjected to one-tailed cluster-based permuta-
tion testing (2000 iterations) using the Monte-Carlo
‘maxsum’ method (Meconi et al., 2016), averaged over
12–20Hz and 0–1.5 s relative to encoding stimulus onset.
The time window of 0–1.5 s post-stimulus onset was
chosen based on findings from previous studies investigat-
ing beta power modulation using the same or similar
memory paradigm (Hanslmayr et al., 2009; Meconi
et al., 2016) and to avoid capturing any motor-related
beta activity prior to the cue for a motor response
(Pfurtscheller and Lopes da Silva, 1999), which appeared
at the end of the encoding period (2 s after encoding
stimulus). Data from all 128 electrodes are included in
all EEG analyses. The only exception is for the additional
correlational analyses in Parkinson’s disease patients to
further investigate the effect of encoding on their beta
power modulation at an individual level, when a subset
of only left frontal electrodes was used based on a litera-
ture-driven prior hypothesis (Hanslmayr et al., 2009,
2011; Meeuwissen et al., 2011). This subset consisted of
the front left quadrant taken from left sagittal to vertex
(D23–A1 on BioSemi cap) and vertex down to mid front-
al (A1–C17). A 2  2 mixed-effects RM ANOVA also
tested for an encoding (shallow, deep)  group
(Controls, Parkinson’s disease) interaction of beta power
and SME averaged for each participant over 0–1.5 s, 12–
20Hz and significant cluster electrodes. Linear regression
tested for a relationship between each Parkinson’s disease
individual’s maximum levels of beta power decrease over
left frontal electrodes during deep-semantic encoding and
(i) memory strength and (ii) disease duration.
The criterion for all statistical significance was a ¼
0.05. Greenhouse–Geisser P-values are reported for non-
spherical data.
Data availability
Anonymized data, not published in the article, will be
shared on reasonable request from a qualified
investigator.
Results
Participants
Twenty-nine adults with Parkinson’s disease and 34
healthy control adults with no known neurological
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impairment were recruited into the study from local
Parkinson’s disease community groups and research vol-
unteer databases. This preregistered recruitment target
(see https://osf.io/vb64n/) was calculated to account for
10% drop out and that some participants might be un-
able to adequately perform the memory task (e.g. insuffi-
cient number of remembered items) while still being
sufficient to detect a large behavioural effect size (Cohn
et al., 2010: Experiment 1) and obtain a power of 0.9.
Data for three control participants were removed due to
not being able to perform the memory task correctly (i.e.
responding to all words in the same way without dis-
crimination), and data for one Parkinson’s disease partici-
pant were removed due to a change in diagnosis.
Demographic information for the remaining 31 control
and 28 Parkinson’s disease participants is provided in
Table 1. Patients were at an average disease duration of
664 years (range 0.3–14) and tested on their normal
medications to avoid the confound of exacerbated motor
symptoms (see Table 2 for demographic and clinical data
for each individual Parkinson’s disease participant). All
participants were native English speakers, had completed
education at secondary or tertiary level, had no history
of dementia, had normal or corrected-to-normal vision
and completed the Oxford Cognitive Screen Plus ques-
tionnaire (Demeyere et al., 2016) as an assessment of glo-
bal cognitive function. The two groups did not differ
with respect to age, global cognitive function or level of
education (all P> 0.254). All results are shown as group
means 6 standard error.
Behavioural
Memory strength
Normal distributions were confirmed for all behavioural
data sets (all P> 0.423). A mixed-effects RM ANOVA
on memory strength (d0) revealed no main effect of group
(F1, 57 ¼ 2.494, P¼ 0.120) but a main effect of encoding
(F1, 57 ¼ 183.499, P< 0.001). Memory performance
improved in both groups with the semantic processing
strategy associated with deep encoding (2.52460.105)
leading to greater memory strength (d0) during
recognition testing compared with shallow encoding
(1.24960.057). There was a group  encoding inter-
action (F1, 57 ¼ 4.885, P¼ 0.031, Fig. 3A). One-tailed
post hoc t-tests revealed no difference in memory strength
between groups following shallow-non-semantic encoding
(t57 ¼ 0.130, P¼ 0.500), but deep-semantic encoding
lead to greater memory strength in control participants
(2.73960.145) compared with Parkinson’s disease
(2.30960.153; t57 ¼ 2.042, P¼ 0.023). Although both
groups demonstrated memory benefits from the semantic
processing required during deep encoding, controls bene-
fited to a greater degree than Parkinson’s disease
participants.
When controlling for age, disease duration had a spe-
cific detrimental effect on mechanisms underlying memory
formation when semantic processing was required in deep
encoding. A least absolute shrinkage and selection oper-
ator regression was run for Parkinson’s disease partici-
pants to correlate disease duration with deep-semantic
and shallow-non-semantic memory strength as well as
age. Only memory strength in the deep-semantic-encoding
condition was significantly negatively correlated with dis-
ease duration (Fig. 3B, F1, 27 ¼ 11.533, P¼ 0.002, other
P> 0.242). A similar regression analysis to correlate age
and memory strength in controls was not performed as
the assumption of normality was violated for age.
Encoding reaction time and accuracy
For reaction time, a mixed-effects RM ANOVA produced
a main effect of encoding (F1, 55 ¼ 6.430, P¼ 0.014) but
no effect of group (F1, 55 ¼ 1.289, P¼ 0.261) or encod-
ing  group interaction (F1, 55 ¼ 0.764, P¼ 0.386). For
both groups, reaction time was faster in shallow-non-se-
mantic encoding (1.1260.03 s) compared with deep-se-
mantic encoding (1.176 0.03 s) by an average of 50ms.
Similarly, for accuracy, there was a main effect of encod-
ing (F1, 55 ¼ 139.156, P< 0.001) but no effect of group
(F1, 55 ¼ 0.044, P¼ 0.834) or encoding  group inter-
action (F1, 55 ¼ 0.119, P¼ 0.732). Accuracy was higher
in shallow-non-semantic encoding (90.96 1.0%) com-
pared with deep-semantic encoding (75.261.1%) for
both groups as expected. The lack of any main effects or
interactions with group indicate the significant difference
in memory strength between groups in the deep-semantic
condition is therefore unlikely to be driven by perceptual
differences during encoding.
EEG
All EEG analysis and presented data are from the ‘encod-
ing stage’. EEG data from one control and two
Parkinson’s disease participants could not be used due to
technical problems or large movements from dyskinesia,
leaving 30 controls and 26 Parkinson’s disease EEG data
sets for analysis.
As hypothesized, the cluster-based permutation testing
on all electrodes showed that controls demonstrated
Table 1 Participant demographics and global cognitive
function
HC Parkinson’s
disease
Age (years) 67 (9) 65 (6)
Education 3.8 (0.4) 3.9 (0.4)
Gender 13F/18M 8F/20M
Disease duration (years) N/A 6 (4)
Handedness 3L/28R 5L/23R
OCS-Plus 9.7 (0.5) 9.7 (0.5)
Values are mean (SD) unless otherwise specified. F ¼ female; HC ¼ healthy controls; M
¼ male; OCS-Plus ¼ Oxford Cognitive Screen Plus questionnaire (maximum 10); L ¼
left-handed; R ¼ right-handed; N/A ¼ not applicable. Education is grouped into 1 ¼ no
formal education; 2 ¼ primary school; 3 ¼ secondary school; and 4 ¼ tertiary level.
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Table 2 Demographic and clinical data for Parkinson’s participants
Subject Age
(years)
Gender Parkinson’s disease medication LEDD
(mg)
Disease
duration (years)
Side
most
affected
1 61 M Stalevo: 375 mg levodopa (5  75 mg/18.75 mg/200 mg)
Ropinirole 8 mg
Rasagiline 1 mg
759 11 R
2 65 F Rasagiline 1 mg
Madopar: 800 mg levodopa (4  50 mg/200 mg)
900 8 L
3 76 F Repinex 8 mg
Sinemet: 500 mg levodopa (4  25 mg/100 mg, 1  25 mg/100 mg
CR)
635 11 L
4 68 M Sinemet: 300 mg levodopa (3  25 mg/100 mg) 300 5 R
5 62 M Stalevo: 200 mg levodopa (4  50 mg/12.5 mg/200 mg)
Rasagiline 1 mg
Apomorphine 3 mg
Repinex 4 mg
476 10 R
6 67 M Madopar: 200 mg levodopa (4  12.5 mg/50 mg)
Rasagiline 1 mg
300 2 L
7 68 M Madopar: 400 mg levodopa (4  25 mg/100 mg)
Rasagiline 1 mg
Repinex 8 mg
660 8 L
8 58 F Madopar: 300 mg levodopa (3  25 mg/100 mg)
Mirapexin 0.26 mg
326 6 L
9 72 M Selegiline 5 mg
Sinemet: 500 mg levodopa (5  25 mg/100 mg)
ReQuipXL 12 mg
Amantadine 300 mg
1090 13 L
10 79 M Rasagiline 1 mg
Ropinirole 8 mg
260 6 R
11 74 M Stalevo: 700 mg levodopa
(3  200 mg/50 mg/200 mg, 1  100 mg/25 mg/200 mg)
Amantadine 300 mg
Rotigotine 16 mg
1711 14 L
12 64 M Mirapexin 1.56 mg 156 3 L
13 67 M Rotigotine 8 mg
Rasagiline 1 mg
Madopar: 400 mg levodopa (4  25 mg/100 mg)
Entacapone 800 mg
1804 10 R
14 67 M Rasagiline 1 mg
Pramipexole 2.1 mg
Sinemet: 300 mg levodopa (3  25 mg/100 mg)
610 4 R
15 61 F None N/A 3 L
16 59 M Rasagiline 1 mg 100 1 R
17 56 F Rasagiline 1 mg
Sinemet: 100 mg levodopa (1  25 mg/100 mg)
Stalevo: 250 mg levodopa (3  50 mg/12.5 mg/200 mg 1  100 mg/
25 mg/200 mg)
Ropinirole 12 mg
773 5 L
18 75 M Rotigotine 6 mgMadopar: 500 mg levodopa (5  25 mg/100 mg) 680 3 L
19 62 F Sinemet: 150 mg levodopa (3  12.5 mg/50 mg) 150 0.33 L
20 58 M Sinemet: 150 mg levodopa (3  12.5 mg/50 mg) 150 1 L
21 70 M Sinemet: 400 mg levodopa (4  25 mg/100 mg) 400 4 L
22 59 F Ropinirole 12 mg
Sinemet: 400 mg levodopa (4  25 mg/100 mg)
640 7 L
23 69 M Madopar: 150 mg levodopa (3  12.5 mg/50 mg) 150 0.5 L
24 62 M Madopar: 700 mg levodopa (6  25 mg/100 mg, 1  25 mg/100 mg
CR)
Ropinirole 16 mg
1020 6 R
25 63 M Requip 10 mg 200 1 L
26 61 F Ropinirole 8 mg
Madopar: 400 mg levodopa (8  12.5 mg/50 mg)
560 4 L
27 54 M Madopar: 400 mg levodopa (4  25 mg/100 mg)
Selegiline 25 mg
650 1 L
28 73 M Sinemet: 400 mg levodopa (4  25 mg/100 mg) 400 8 R
LEDD ¼ levodopa equivalent daily dose; M ¼ male; F ¼ female; CR ¼ continuous release; L ¼ left; R ¼ right; N/A ¼ not applicable.
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greater beta power decreases during deep-semantic encod-
ing of subsequently remembered words (Hits) compared
with Parkinson’s disease participants (cluster stat ¼
150.1, P¼ 0.014; Fig. 4A and B shows beta power
decreases for electrodes in significant cluster); however,
no difference between groups emerged during shallow-
non-semantic encoding (cluster stat ¼ 3.7, P¼ 0.326;
Fig. 4C and D shows beta power decreases for electrodes
in largest cluster that did not reach significance). A
mixed-effects RM ANOVA on averaged beta (over 0–
1.5 s, 12–20Hz) further supported this finding by produc-
ing a significant encoding  group interaction (F1, 54 ¼
6.959, P¼ 0.011) that confirms the difference between
groups in deep-semantic encoding (t54 ¼ 2.910,
P¼ 0.005) is significantly different to shallow-non-seman-
tic encoding (t54 ¼ 1.030, P¼ 0.307). There were no
main effects of encoding (F1, 54 ¼ 0.612, P¼ 0.437) or
group (F1, 54 ¼ 3.946, P¼ 0.052). Therefore, a difference
between decreases in beta power across groups is seen
only in the deep-semantic-encoding condition, indicating
that there is a deficit when decreasing beta power in the
Parkinson’s disease group that occurs specifically during
deep-semantic processing.
Cluster-based permutation testing on all electrodes in
the alpha and theta frequency ranges showed no signifi-
cant between-group differences in power (alpha: cluster
stat ¼ 8.9, P¼ 0.219; theta: no significant clusters were
identified). This confirms that our between-group differ-
ences detailed above are specific to the beta frequency
range.
The relationship between decreases in beta power and
the deep-semantic-encoding condition is reinforced by the
similar pattern of beta power seen during the encoding of
words that were not successfully remembered (M). M in
controls were associated with greater decreases in beta
power during deep-semantic encoding when compared
with Parkinson’s disease participants (cluster stat ¼
54.1, P¼ 0.031); however, no difference between
groups emerged during shallow-non-semantic encoding
(cluster stat ¼ 3.8, P¼ 0.330). A mixed-effects RM
ANOVA similarly produced main effects of encoding (F1,
54 ¼ 5.450, P¼ 0.023) and group (F1, 54 ¼ 6.155,
P¼ 0.016) and a significant encoding  group interaction
(F1, 54 ¼ 5.975, P¼ 0.018). The interaction confirms the
difference between groups in deep-semantic encoding (t54
¼ 3.367, P¼ 0.001) is significantly different to shallow-
non-semantic encoding (t54 ¼ 0.919, P¼ 0.362). The fact
that a difference in beta power is seen between groups
during encoding of both remembered and forgotten items
implies the difference is related to deep-semantic process-
ing in general. This overall reduction in beta power
modulation and thereby impaired deep-semantic process-
ing may lead to reduced memory performance in
Parkinson’s disease participants.
Successful memory formation specifically involving
deep-semantic processing was associated with greater
reductions in beta power. Within groups, controls dem-
onstrated greater decreases in beta power for subsequent-
ly remembered words during deep-semantic compared
with shallow-non-semantic encoding (cluster stat ¼
94.4, P¼ 0.012; Fig. 4E and F shows beta power
decreases for electrodes in significant cluster).
Interestingly, at a group level, Parkinson’s disease partici-
pants did not show significantly greater reductions in
beta power in deep-semantic encoding compared with
shallow-non-semantic (no significant clusters were identi-
fied), although they did show a behavioural benefit of
deep-semantic encoding, albeit to a lesser extent than
controls. Based on findings of left IFC beta being specific-
ally linked to memory strength in healthy controls
(Hanslmayr et al., 2009, 2011; Meeuwissen et al., 2011),
we did an additional correlational analysis focusing on
left frontal beta in Parkinson’s disease patients. Despite
no group-level effect, linear regressions illustrated that
Parkinson’s disease participants who showed greater beta
power decreases over left frontal electrodes also had sig-
nificantly greater memory strength during deep-semantic
encoding (P¼ 0.008, R2 ¼ 0.256, Fig. 5A) but that dis-
ease duration negatively correlated with left frontal max-
imum decreases in beta power (P¼ 0.007, R2 ¼ 0.263,
Fig. 5B). Parkinson’s disease participants earlier in the
disease who were able to achieve greater reductions in
beta power in left frontal electrodes benefited more from
deep-semantic-encoding strategies of memory formation.
The secondary dependent measure was the SME in
beta power, which compared power between Hit (i.e.
subsequently remembered with high or low confidence)
and M (i.e. subsequently forgotten) trials (Brewer et al.,
1998; Otten et al., 2001; Hanslmayr et al., 2009). This
Figure 3 Memory performance. (A) Memory performance
during encoding conditions illustrating greater memory strength
during deep-semantic encoding for healthy controls (N¼ 31)
compared with Parkinson’s disease participants (N¼ 28). Error bars
denote standard error of the mean. *P< 0.05. (B) Correlation
between deep encoding memory performance and disease duration
for Parkinson’s disease participants (P¼ 0.002).
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Figure 4 Event-related decreases in beta power. Average beta (12–20 Hz) event-related power decrease for electrodes in significant and/
or largest cluster identified during cluster-based statistical analysis. Top row: between-group differences during deep-semantic encoding of
remembered words; middle row: between-group differences during shallow-non-semantic encoding of remembered words; bottom row:
differences within healthy participants between deep-semantic and shallow-non-semantic encoding of remembered words. Grey dashed squares
indicate time window used in statistical analysis to identify significant electrode clusters over 12–20 Hz. Time course of decreases in beta power
averaged over electrodes contributing to significant and/or largest cluster during encoding of subsequently successfully remembered words for
controls (blue, N¼ 30) compared with Parkinson’s disease participants (red, N¼ 26) in the deep-semantic-encoding (A) and shallow-non-
semantic-encoding (C) conditions. A power decrease is denoted with negative values. Only deep-semantic encoding showed a significant
difference between groups (electrodes contributing to significant cluster black in B). Topographical maps show the location of the differences in
beta power decreases between groups in deep (B) and shallow (D) encoding, with colder colours indicating significantly greater decreases in
beta power in controls compared with Parkinson’s disease participants. Cluster shown for shallow-non-semantic encoding in C and D did not
reach significance. (E) Time course of beta power decrease averaged over electrodes contributing to significant cluster during encoding of
subsequently successfully remembered words for deep-semantic (green) compared with shallow-non-semantic encoding (magenta) in controls. A
power decrease is denoted with negative values. Only controls showed a significant difference between encoding conditions (electrodes
contributing to significant cluster black in F). Topographical map in F shows the location of differences in beta power decreases between
encoding conditions, with colder colours indicating significantly greater reductions in beta power in deep-semantic compared with shallow-non-
semantic encoding. No cluster identified between encoding conditions for Parkinson’s disease patients.
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categorization in the ‘encoding stage’ depended on the
participant’s response in the ‘recognition stage’ and their
individualized receiver operating characteristic curves
(Hanslmayr et al., 2009). A minimum of five trials was
required for Hits and M, resulting in N¼ 27 for controls
and N¼ 25 for Parkinson’s disease participants in the
SME analysis. The SME results broadly replicated a num-
ber of previous findings (Hanslmayr et al., 2009, 2011;
Meconi et al., 2016) and further support the importance
of decreases in beta power as the mechanism underlying
successful memory formation through deep-semantic-
encoding strategies: there was a significant SME in deep-
semantic encoding for controls (cluster stat ¼ 39.8,
P¼ 0.037, Fig; 6A and B illustrates beta power decreases
for electrodes in significant cluster) and Parkinson’s dis-
ease participants (cluster stat ¼ 78.7, P¼ 0.008;
Fig. 6C and D illustrates beta power decreases for elec-
trodes in significant cluster). Importantly, there was no
significant SME associated with shallow-non-semantic
encoding (controls: cluster stat ¼ 14.6, P¼ 0.182;
Fig. 6E and F illustrates beta power decreases for electro-
des in largest cluster that did not reach significance;
Parkinson’s disease: cluster stat ¼ 2.0, P¼ 0.755;
Fig. 6G and H illustrates beta power decreases for elec-
trodes in largest cluster that did not reach significance).
A mixed-effects RM ANOVA showed a main effect of
encoding (F1, 54 ¼ 17.389, P< 0.001), confirming that
deep-semantic encoding produced a greater average SME
(56 1%) compared with shallow-non-semantic encoding
(0.36 0.7%). There was no main effect of group (F1, 54
¼ 0.221, P¼ 0.640) or encoding  group interaction (F1,
54 ¼ 0.073, P¼ 0.788). The lack of an interaction indi-
cates that, although Parkinson’s disease participants
remembered fewer items than controls following deep-se-
mantic encoding, the remembered items in both groups
were accompanied by similar electrophysiological signa-
tures (i.e. SME) and, in both cases, they lead to the same
behavioural outcome—that of remembering (i.e. d0 above
zero).
Discussion
The study confirmed our preregistered hypotheses and
produced several novel findings that provide the first
evidence of impaired modulation of beta power being
associated with a non-motor symptom of Parkinson’s
disease. Parkinson’s disease participants showed
impaired memory strength compared with healthy con-
trols but only following deep-semantic encoding of
words. This behavioural finding was mirrored by the
EEG results which demonstrated that Parkinson’s dis-
ease participants exhibited reduced beta power
decreases compared with healthy controls but again
only during deep-semantic processing. Furthermore, a
correlation between disease duration and an increased
deficit in deep-semantic encoding suggested that the
neuropathology of Parkinson’s disease has a specific
detrimental effect on the mechanisms underlying deep-
semantic information processing leading to both
reduced beta power decreases and reduced memory
strength. This is reinforced by that fact that participants
with Parkinson’s disease who showed greater beta
power decreases over left frontal electrodes benefited to
a greater extent from the deep-semantic-encoding mem-
ory strategy. There were no differences between the
groups in age, global cognitive function, education or
perception during encoding that could explain these be-
havioural or EEG results. Therefore, our results appear
to be specific to deep-semantic processing. Overall, our
findings strengthen the idea that dysfunctional beta
oscillations are likely to be the cause of Parkinson’s dis-
ease symptoms in both motor and non-motor domains.
Parkinson’s disease did not cause impaired memory
performance in general, but rather a specific deficit in
deep-semantic encoding of memory. Deep-semantic encod-
ing in the context of the current study utilized general
knowledge about the word to form an abstract represen-
tation and evaluate the representation as animate or in-
animate. Age-related memory decline is a widely
acknowledged fact that is seen across several subdomains,
including episodic memory (e.g. see Shing et al., 2010).
Over and above the aging-related decline, a further de-
cline in episodic memory resulting from deep-semantic
encoding appeared to be caused by the mechanisms
underlying Parkinson’s disease. Replicating previous find-
ings, Parkinson’s disease participants were able to employ
the non-semantic-encoding strategy to build a memory
trace of equivalent strength to controls (Cohn et al.,
2010). The difference in memory performance between
groups was only elucidated following a deep-semantic-
encoding instruction. In contrast to Cohn et al. (2010),
the current Parkinson’s disease participants still showed a
behavioural benefit from the deep-semantic-encoding
Figure 5 Correlations in Parkinson’s disease patients.
(A) Correlation between deep-semantic-encoding memory
performance and maximum decrease in beta power over left frontal
electrodes for Parkinson’s disease participants (N¼ 26, P¼ 0.008,
R2 ¼ 0.256). (B) Correlation between maximum decrease in beta
power over left frontal electrodes and disease duration for
Parkinson’s disease participants (N¼ 26, P¼ 0.007).
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Figure 6 Subsequent-memory effects. Average beta (12–20 Hz) event-related power decreases for electrodes in significant and/or largest
cluster identified during cluster-based statistical analysis. Top row: differences within healthy participants between remembered and forgotten
words during deep-semantic encoding; second row: differences within Parkinson’s disease participants between remembered and forgotten
words during deep-semantic encoding; third row: differences within healthy participants between remembered and forgotten words during
shallow-non-semantic encoding; bottom row: differences within Parkinson’s disease participants between remembered and forgotten words
during shallow-non-semantic encoding. Grey dashed squares indicate time window used in statistical analysis to identify significant electrode
clusters over 12–20 Hz. Time course of decrease in beta power averaged over electrodes contributing to significant and/or largest cluster during
Hit (H, cyan) compared with M (yellow) trials in deep encoding for controls (A, N¼ 27) and Parkinson’s disease participants (C, N¼ 25). Both
groups demonstrated greater reductions in beta power during encoding of subsequently remembered (H) compared with forgotten (M) words,
but only the clusters in deep-semantic encoding reached significance (electrodes contributing to significant cluster black in B and D).
Topographical maps show the location of differences in beta power decrease between words in deep-semantic encoding for controls (B) and
Parkinson’s disease patients (D), with colder colours indicating greater reductions in beta power for remembered compared with forgotten
words. Time course and location of decreases in beta power averaged over electrodes contributing to largest, non-significant cluster during H
(cyan) compared with M (yellow) trials in shallow-non-semantic encoding for controls (E and F, N¼ 27) and Parkinson’s disease participants (G
and H, N¼ 25).
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memory strategy and those who were less progressed in
the disease benefited to a greater degree. People with
Parkinson’s disease struggle to spontaneously implement
the optimal memory encoding strategy (Knoke et al.,
1998). However, with explicit encoding instructions,
Parkinson’s disease participants managed to improve
memory with the optimal deep-semantic-encoding strat-
egy, albeit to a lesser degree than controls. This finding
suggests that they are able to recruit the neural mecha-
nisms to process semantic information about the words
in the deep encoding condition, but something prevents
the level of processing reaching that of controls and
reduces memory strength. This finding is in line with
other behavioural evidence of impaired semantic process-
ing in Parkinson’s disease (Cousins and Grossman,
2017). Overall, people with Parkinson’s disease exhibited
a limited deep-semantic processing capacity during mem-
ory encoding rather than a general deficit in recognition
memory.
The deficit in episodic memory performance following
a deep-semantic-encoding strategy displayed by
Parkinson’s disease participants was associated with a
reduced dynamic range of beta power during encoding.
Brain oscillations are considered one of the core neural
mechanisms for the storage and retrieval of long-term
memories (Buzsaki and Draguhn, 2004; Fell and
Axmacher, 2011) and the extent of decreases in neural
oscillations is thought to relate to the degree of informa-
tion stored in the brain (Hanslmayr et al., 2012). In the
current study, the greater level of beta power decreases
for deep-semantic versus shallow-non-semantic encoding
and words that were subsequently remembered compared
with those that were not further support the importance
of decreases in beta power as the mechanism underlying
successful deep-semantic memory formation (Sederberg
et al., 2006; Hanslmayr et al., 2009, 2011; Meeuwissen
et al., 2011; Meconi et al., 2016). As both groups dis-
played similar behavioural outcomes of deep-semantic
encoding (i.e. d0 values above zero, although Parkinson’s
disease participants remembered fewer items than con-
trols), it is not surprising that both groups displayed simi-
lar electrophysiological differences between Hit and M
trials (i.e. an SME). Importantly, however, overall
decreases in beta power were significantly reduced in
Parkinson’s disease participants compared with controls
during deep-semantic processing, but not for words
encoded with a shallow-non-semantic strategy. This dis-
tinction implies that a reduced capacity to decrease beta
power following stimulus presentation for Parkinson’s
disease participants reduced the effectiveness of semantic
processing, leading to fewer successfully recognized words
and a lower d0 value.
It has been proposed that the relative change in pre- to
post-stimulus power is most important for memory per-
formance, rather than absolute power levels (Klimesch
et al., 2003; Klimesch et al., 2006). Parkinson’s disease
participants demonstrated decreases in the reactivity of
their event-related beta power and therefore reduced
encoding capacity. Parkinson’s disease participants who
were further progressed in the disease demonstrated fur-
ther reductions in both beta reactivity and memory
strength. A reduced dynamic range of BG–thalamocortical
beta power in Parkinson’s disease can therefore interfere
with other neural mechanisms that operate in the beta
frequency range apart from movement, including memory
formation.
The neural changes causing episodic memory deficits in
Parkinson’s disease may be the same as those underlying
motor symptoms. Memory formation recruits an exten-
sive network of mainly left-lateralized regions for verbal
material. This network includes the anterior temporal
lobe for storage of conceptual representations and proc-
essing concepts at an abstract level (Jefferies and Lambon
Ralph, 2006; Patterson et al., 2007) and the IFC and
temporoparietal region for strategic search and control
processes that are necessary for semantic processing
(Jefferies and Lambon Ralph, 2006; Binder et al., 2009;
Jefferies, 2013). The extent of beta power decreases in
left prefrontal cortex, specifically IFC, has been linked to
memory performance (Hanslmayr et al., 2009, 2011).
Function of the prefrontal cortex is heavily influenced by
the integrity of dopaminergic input onto frontostriatal
connections. Therefore, it is not surprising that dopamin-
ergic dysfunction seen in Parkinson’s disease leads to
impaired IFC function, observed in motor tasks that re-
cruit the right IFC as part of the response inhibition net-
work (Gauggel et al., 2004; Bokura et al., 2005; Obeso
et al., 2011; Swann et al., 2011). We have extended these
findings to also show impairment during a memory task
that has been shown to recruit the left IFC during deep-
semantic encoding. Previous studies have highlighted the
ability of BG oscillatory activity to influence cortical
neuronal oscillations recorded with surface EEG
(Horschig et al., 2015; Chung et al., 2018). We therefore
propose that the same pathological BG beta mechanism
causing the motor symptoms in Parkinson’s disease is
contributing to the deficit in deep-semantic encoding of
memory seen in the current study. This would imply a
common neural mechanism may underlie a variety of def-
icits in Parkinson’s disease that involve cortico-BG proc-
esses, which operate predominantly in the beta frequency
range.
Identifying a common neural mechanism behind the
motor and non-motor symptoms of Parkinson’s disease
has implications for treatment and disease monitoring.
There are currently no standard treatment options for
mild memory and cognitive problems in Parkinson’s dis-
ease (i.e. mild cognitive impairment). Applying interven-
tions previously shown to decrease exaggerated beta
activity such as deep brain stimulation or dopamine re-
placement therapy (Ray et al., 2008; Eusebio et al.,
2011) should in theory also help with memory deficits
caused by the same pathology. Considering the inverse
relationship demonstrated in the current study between
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disease progression and both memory performance and
decreases in beta power, it is feasible that this memory
paradigm could be developed as a useful surrogate to
measure functional beta reactivity. As such, the paradigm
could be used as a new and convenient behavioural test
to monitor disease progression, with specific applications
in telemedicine.
It is important to note that, while we present findings
that the neural changes causing episodic memory deficits
in Parkinson’s disease may resemble those underlying
motor symptoms, we do not posit that reduced beta re-
activity is the sole deficit that emerges in Parkinson’s dis-
ease. Nor, in fact, that there is a single source of beta
that homogenizes symptomology across domains (Spitzer
and Haegens, 2017). Instead, we extend the impact of a
deficit that has been identified in the motor domain to
other (cognitive) areas. This will likely explain some
symptoms well, but not all, and should be a consider-
ation when titrating medications to alleviate different
aspects of motor and/or cognitive performance. It is im-
portant to make this distinction as we are not claiming
that beta observed in the motor system directly influences
memory encoding—but that beta in memory-relevant
areas is also deficient and, while these rhythms are likely
to serve a similar functional role, deficits may indeed be
graded across functional areas. Hence, motor deficits and
memory deficits may be differentially influenced depend-
ing on the underlying pathophysiological state.
There are a few limitations to the current study that
should be considered. First, the relationship between beta
power and the behavioural deficit in the Parkinson’s dis-
ease group is correlational. However, it is the more parsi-
monious explanation that a common underlying
neurological deficit (i.e. impaired modulation of beta
power) causes both motor and memory problems than
two unrelated behavioural symptoms producing the same
epiphenomenon in the beta system. Furthermore, evidence
exists for a causal relationship between the strength of
beta power decreases in left prefrontal cortex and mem-
ory performance (Hanslmayr et al., 2014) so the direct
relationship shown in the current study would support a
causal role of pathological beta in Parkinson’s disease
symptomology. Extending the findings from Hanslmayr
and colleagues, future studies could use transcranial mag-
netic stimulation to modulate left prefrontal beta in peo-
ple with Parkinson’s disease and look for a causal
influence on their episodic memory performance. Second,
beta power modulation also plays a role in memory re-
trieval (Dujardin et al., 1994; Duzel et al., 2003) and
people with Parkinson’s disease are thought to use ineffi-
cient retrieval strategies (Zakzanis and Freedman, 1999).
However using recognition, which is one of the simplest
ways to test episodic memory, greatly reduced retrieval
demands in our task, e.g. compared with free or cued re-
call. A retrieval based explanation for our behavioural
findings is therefore rather unlikely. Nevertheless, we can-
not completely discount the contribution of impaired beta
power decreases during retrieval to the reduced recogni-
tion memory performance in our study.
Despite displaying topographical maps in an effort to
show the location of beta power differences between
groups, the methods used in the current study cannot be
used to form a robust conclusion about spatial differences
in beta power modulation. The location of beta differen-
ces in deep-semantic encoding between patients and
healthy participants seemed to indicate a widespread cor-
tical deficit in beta power modulation in Parkinson’s dis-
ease patients, which included the left frontal region. This
widespread difference is in contrast to, for example more
focal differences in beta power decreases for healthy par-
ticipants between deep-semantic and shallow-non-seman-
tic encoding. However, scalp-level EEG has limited
spatial resolution. Subsequent studies using magnetoence-
phalography with a much higher spatial resolution would
be needed to investigate these results further. Finally,
when considering the generalizability of our results, it is
worth noting that the Parkinson’s disease patients in the
current study were mild to moderately impaired in terms
of disease severity. Our study therefore cannot directly
speak to the relationship between memory impairments
and beta oscillations in severely affected Parkinson’s dis-
ease patients. However, our findings of an inverse rela-
tionship between disease duration and both memory
performance and beta activity speaks to a general charac-
terization that will likely extend (alongside other age-
related factors) to those severely impaired patients.
Conclusion
This study provides the first evidence of impaired beta
modulation being associated with a non-motor symptom
of Parkinson’s disease. Parkinson’s disease participants
showed impaired memory strength and decreases in beta
power compared with healthy controls during deep-se-
mantic encoding. The neuropathology of Parkinson’s dis-
ease seemed to have a specific detrimental effect on the
mechanisms underlying episodic memory formation in a
deep-semantic-encoding task leading to both reduced
memory strength and reduced beta modulation. We pro-
pose that the neural changes causing memory deficits in
Parkinson’s disease may be the same as those underlying
motor symptoms, i.e. impaired modulation of beta activ-
ity within BG–thalamocortical circuitry. Importantly, the
decrease in beta modulation shown in our study cannot
be explained away as an epiphenomenon that scales with
decreased movement in Parkinson’s disease. Our findings
strengthen the idea that dysfunctional beta oscillations
are causal in Parkinson’s disease symptomology and ex-
tend their implications to non-motor symptoms of the
disease.
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